BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 62791)

  • 1. Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
    Parmely MJ; Thompson JS
    J Immunol; 1976 Nov; 117(5 Pt.2):1832-7. PubMed ID: 62791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-fetoprotein on murine immune responses. II. Studies on rats.
    Sell S; Sheppard HW; Poler M
    J Immunol; 1977 Jul; 119(1):98-103. PubMed ID: 68979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
    Ren EC; Chan SH
    J Natl Cancer Inst; 1981 Apr; 66(4):625-30. PubMed ID: 6164810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditions affecting the immunosuppressive properties of human alpha-fetoprotein.
    Goeken NE; Thompson JS
    J Immunol; 1977 Jul; 119(1):139-42. PubMed ID: 68967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. III. Role of the MLC-stimulating cell population in alpha-fetoprotein-induced suppression of T cell-mediated cytotoxicity.
    Peck AB; Murgita RA; Wigzell H
    J Immunol; 1982 Mar; 128(3):1134-40. PubMed ID: 6173421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human lymphocyte activation by alpha-fetoprotein. Evidence for selective suppression of Ia-associated T-cell proliferation in vitro.
    O'Neill G; Tsega E; Gold P; Murgita RA
    Oncodev Biol Med; 1982; 3(2-3):135-50. PubMed ID: 6181483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive activity of isolated rat and human fetoproteins.
    Goeken NE; Parmely MJ; Thompson JS
    Immunol Commun; 1978; 7(2):125-36. PubMed ID: 77247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetoprotein-producing hepatoma cells in vitro.
    Nishina K; Tsutamune T; Tokiwa T; Miyazaki M; Sato J
    Acta Med Okayama; 1975 Aug; 29(4):319-26. PubMed ID: 55059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro correlates of rejection. I. Suppressive effect and specificity in mixed lymphocyte interaction of alloantiserum producing hyperacute rejection.
    Guttmann RD
    Transplant Proc; 1977 Mar; 9(1):755-60. PubMed ID: 68601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
    Allen RP; Ledford BE
    Cancer Res; 1977 Mar; 37(3):696-701. PubMed ID: 65216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression.
    Yachnin S; Lester E
    Clin Exp Immunol; 1976 Dec; 26(3):484-90. PubMed ID: 64327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-alpha1-fetoprotein on alpha1-fetoprotein-producing rat tumors in vivo and in vitro.
    Sell S; Sheppard HW; Nickel R; Stillman D; Michaelsen M
    Cancer Res; 1976 Feb; 36(2 Pt 1):476-80. PubMed ID: 56992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis.
    Huang DP; Schwartz CE; Chiu JF; Cook JR
    Cancer Res; 1984 Jul; 44(7):2976-80. PubMed ID: 6202403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.
    Yachnin S
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro].
    Wang XW; Xie H
    Shi Yan Sheng Wu Xue Bao; 1999 Mar; 32(1):15-22. PubMed ID: 12548790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and immunochemical characterization of alpha-fetoprotein from rat fetal serum and liver.
    Watanabe A; Mori O; Taketa K; Kosaka K
    Acta Med Okayama; 1975 Oct; 29(5):355-66. PubMed ID: 58541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Fetoprotein as a carrier protein in plasma and its bilirubin-binding ability.
    Aoyagi Y; Ikenaka T; Ichida F
    Cancer Res; 1979 Sep; 39(9):3571-4. PubMed ID: 89900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
    Sonnenschein C; Ucci AA; Soto AM
    J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of primary and secondary autologous mixed lymphocyte reactions by murine alphafetoprotein.
    Hooper DC; Pagida E; Murgita RA
    Oncodev Biol Med; 1982; 3(2-3):151-60. PubMed ID: 6181484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.